Whereas the latter assays provide good sensitivity for determining ER status and good specificity for those of PR and ERBB2, improvements of these parameters would be desirable to more accurately predict the status of the expression of these genes in breast tumor gene expression profiles. This evidence concerns the gene ESR1 and breast neoplasm.